Drug rash with eosinophilia and systemic symptoms after penicillin V administration in a patient with acquired C1 inhibitor acquired deficiency.
Doña
I
I
Allergy Service, Carlos Haya Hospital, Málaga, Spain. inmadd@hotmail.com
Chaves
P
P
Gómez
E
E
Torres
Ma J
MJ
Cantó
L G
LG
Blanca
M
M
D000328:Adult; D019072:Antibiotic Prophylaxis / Q000009:adverse effects*; D015703:Antigens, CD / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D003174:Complement C1 Inactivator Proteins / Q000235:genetics* / Q000276:immunology / Q000378:metabolism; D050718:Complement C1 Inhibitor Protein; D004342:Drug Hypersensitivity / Q000175:diagnosis / Q000235:genetics* / Q000503:physiopathology / Q000628:therapy; D004802:Eosinophilia / Q000139:chemically induced; D005076:Exanthema / Q000139:chemically induced; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology; D008297:Male; D010404:Penicillin V / Q000008:administration & dosage / Q000009:adverse effects*; D013154:Spleen / Q000000981:diagnostic imaging / Q000276:immunology / Q000601:surgery; D013601:T-Lymphocytes / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D014463:Ultrasonography; D014581:Urticaria / Q000139:chemically induced
D015703:Antigens, CD; D003174:Complement C1 Inactivator Proteins; D050718:Complement C1 Inhibitor Protein; C469952:SERPING1 protein, human; D010404:Penicillin V